Gerard A. Potter

Novel Steroidal Inhibitors of Human Cytochrome P45017.alpha.-Hydroxylase-C17,20-lyase): Potential Agents for the Treatment of Prostatic Cancer

Gerard A. Potter, S. Elaine Barrie, Michael Jarman et al. · Journal of Medicinal Chemistry · 1995 · 380 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1

Gerard A. Potter, L. H. Patterson, E Wanogho et al. · British Journal of Cancer · 2002 · 375 citations · Full text

Medicine, Biochemistry, Pharmacology +17

Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene

S. Sale, Richard D. Verschoyle, David J. Boocock et al. · British Journal of Cancer · 2004 · 259 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Pharmacology of novel steroidal inhibitors of cytochrome P45017 (17α-hydroxylase/C17–20 lyase)

S. Elaine Barrie, Gerard A. Potter, Phyllis M. Goddard et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1994 · 255 citations

Medicine, Medicinal Chemistry, Pharmacology +16

A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism

Gerard A. Potter, Raymond McCague, Michael Jarman · Carcinogenesis · 1994 · 104 citations

Pharmacy, Pharmacology, Toxicology +15